Stroke, Acute Clinical Trial
Official title:
Whole-process Quality Improvement of Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment Based on an Artificial Intelligence-aided Clinical Feedback System
A clustered randomized control trial to evaluate whether multi-aspect intervention based on an AI-aided clinical feedback system could improve the quality of EVT and functional outcome of patients.
Status | Recruiting |
Enrollment | 1221 |
Est. completion date | September 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age > 18 - AIS patients receiving EVT within 24 hours of stroke onset - Written informed consent is obtained Exclusion Criteria: - Patients refuse to participate in this study |
Country | Name | City | State |
---|---|---|---|
China | Second Affiliated Hospital, School of Medicine, Zhejiang University | Hangzhou |
Lead Sponsor | Collaborator |
---|---|
Second Affiliated Hospital, School of Medicine, Zhejiang University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Ratio of favorable functional outcome at 3 month in patients within 6 hours of stroke onset | Ratio of mRS > 2 at 3 month follow-up in patients within 6 hours of stroke onset | 3 months | |
Other | Door to groin puncture time in patients within 6 hours of stroke onset | Time interval between admission and groin puncture in patients within 6 hours of stroke onset | 24 hours | |
Primary | Ratio of favorable functional outcome at 3 month | Ratio of patients with mRS > 2 at 3-month follow up | 3 months | |
Secondary | Ratio of good functional outcome at 3 month | Ratio of patients with mRS > 1 at 3-month follow up | 3 months | |
Secondary | mRS score at 3 month | mRS score at 3-month follow up | 3 months | |
Secondary | Mortality at 3 month | Mortality at 3-month follow up | 3 months | |
Secondary | Ratio of hemorrhagic transformation at 24 hour | Ratio of hemorrhagic transformation at 24 hour after EVT | 24 hours | |
Secondary | Ratio of symptomatic intracranial hemorrhage at 24 hour | Ratio of symptomatic intracranial hemorrhage at 24 hour after EVT | 24 hours | |
Secondary | Door to groin puncture time | Time interval between admission and groin puncture | 24 hours | |
Secondary | Ratio of door to groin puncture time < 90 min | Time interval between admission and groin puncture <90 min | 24 hours | |
Secondary | Ratio of door to groin puncture time < 60 min | Time interval between admission and groin puncture <60 min | 24 hours | |
Secondary | Procedural duration | Time interval between groin puncture and last time of digital subtraction angiography | 24 hours | |
Secondary | Ratio of successful reperfusion | Ratio of patients achieving modified thrombolysis in cerebral infarction (mTICI) 2b or 3 | 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|